Kunming Longjin Pharmaceutical Co., Ltd. announced earnings results for the full year ended December 31, 2019. For the full year, the company announced sales was CNY 275.292 million compared to CNY 335.984 million a year ago. Operating loss was CNY 21.954 million compared to operating Income of CNY 16.695 million a year ago. Net loss was CNY 23.107 million compared to net income of CNY 13.870 million a year ago. Basic loss per share from continuing operations was CNY 0.0577 compared to basic earnings per share from continuing operations of CNY 0.0346 a year ago.